{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/6490a6a7bf64170011e867ff/6afb1120b2404cde2f01b686?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Looking Back at the GRAPPA Advanced Clinical Forum on Obesity – And Looking Ahead","description":"<p>In this episode of <em>Inside GRAPPA</em>, GRAPPA Education Committee Co-Chairs Dr. Katy Leung (Singapore), Dr. Elaine Husni (USA), and Dr. Luis Puig (Spain) reflect on the key themes and insights from the recent GRAPPA Advanced Clinical Forum on Obesity.</p><p><br></p><p><strong>Topics include:</strong></p><ul><li>Why obesity has become a priority in psoriatic disease </li><li>Major scientific and clinical themes from the forum </li><li>Integrating obesity management into routine clinical practice </li><li>Future GRAPPA educational initiatives and enduring content on obesity in psoriatic disease</li></ul><p><br></p><p><em>The Advanced Clinical Forum on Obesity was supported by Eli Lilly and Company through an independent sponsorship.</em></p><p><br></p><p>To learn more about GRAPPA and upcoming educational programs, visit <u><a href=\"http://www.grappanetwork.org\" rel=\"noopener noreferrer\" target=\"_blank\">www.grappanetwork.org</a></u></p>","author_name":"GRAPPA Network"}